Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Comparative analysis of targeted next-generation sequencing for Plasmodium falciparum drug resistance markers.
Kunasol C. et al, (2022), Scientific reports, 12
Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response.
Zhu L. et al, (2022), Communications biology, 5
Facilitating safe discharge through predicting disease progression in moderate COVID-19: a prospective cohort study to develop and validate a clinical prediction model in resource-limited settings.
Chandna A. et al, (2022), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project
Chandna A. et al, (2022), Wellcome Open Research, 6, 64 - 64
Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
Peto TJ. et al, (2022), The Lancet Infectious Diseases
Community engagement for malaria elimination in the Greater Mekong Sub-region: a qualitative study among malaria researchers and policymakers.
Kaehler N. et al, (2022), Malaria journal, 21
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Murray CJL. et al, (2022), The Lancet, 399, 629 - 655
Have we really failed to roll back malaria?
White NJ. et al, (2022), Lancet (London, England), 399, 799 - 800
Assessment in vitro of the antimalarial and transmission blocking activities of Cipargamin and Ganaplacide in artemisinin resistant Plasmodium falciparum.
Yipsirimetee A. et al, (2022), Antimicrobial agents and chemotherapy
Anti-Gametocyte Antigen Humoral Immunity and Gametocytemia During Treatment of Uncomplicated Falciparum Malaria: A Multi-National Study.
O'Flaherty K. et al, (2022), Frontiers in cellular and infection microbiology, 12
Co-evolutionary Signals Identify Burkholderia pseudomallei Survival Strategies in a Hostile Environment.
Chewapreecha C. et al, (2022), Molecular biology and evolution, 39
Blood transcriptomics to characterize key biological pathways and identify biomarkers for predicting mortality in melioidosis.
Yimthin T. et al, (2021), Emerging microbes & infections, 10, 8 - 18
Clustering of malaria in households in the Greater Mekong Subregion: operational implications for reactive case detection
Mukaka M. et al, (2021), Malaria Journal, 20
Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling study.
Browne AJ. et al, (2021), The Lancet. Planetary health, 5, e893 - e904
Evolution of Multidrug Resistance in Plasmodium falciparum: a Longitudinal Study of Genetic Resistance Markers in the Greater Mekong Subregion
Imwong M. et al, (2021), Antimicrobial Agents and Chemotherapy, 65
Effect of Delays in Concordant Antibiotic Treatment on Mortality in Patients With Hospital-Acquired Acinetobacter Species Bacteremia: Emulating a Target Randomized Trial With a 13-Year Retrospective Cohort
Lim C. et al, (2021), American Journal of Epidemiology, 190, 2395 - 2404
Evaluation of antigen-detecting and antibody-detecting diagnostic test combinations for diagnosing melioidosis
Amornchai P. et al, (2021), PLOS Neglected Tropical Diseases, 15, e0009840 - e0009840
Antimicrobial use and resistance data in human and animal sectors in the Lao PDR: evidence to inform policy
Chansamouth V. et al, (2021), BMJ Global Health, 6, e007009 - e007009
Effect of Delays in Concordant Antibiotic Treatment on Mortality in Patients With Hospital-Acquired Acinetobacter Species Bacteremia: Emulating a Target Randomized Trial With a 13-Year Retrospective Cohort.
Lim C. et al, (2021), American journal of epidemiology, 190, 2395 - 2404
Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial
McLean ARD. et al, (2021), The Lancet Infectious Diseases, 21, 1579 - 1589